IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
9.77
+0.23 (2.36%)
Nov 20, 2024, 4:00 PM EST - Market closed
IGM Biosciences Employees
IGM Biosciences had 224 employees as of December 31, 2023. The number of employees decreased by 34 or -13.18% compared to the previous year.
Employees
224
Change (1Y)
-34
Growth (1Y)
-13.18%
Revenue / Employee
$13,027
Profits / Employee
-$981,442
Market Cap
580.67M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 224 | -34 | -13.18% |
Dec 31, 2022 | 258 | 66 | 34.38% |
Dec 31, 2021 | 192 | 85 | 79.44% |
Dec 31, 2020 | 107 | 43 | 67.19% |
Dec 31, 2019 | 64 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Auna S.A. | 14,958 |
Standard BioTools | 539 |
Axogen | 428 |
Surmodics | 376 |
Simulations Plus | 197 |
Humacyte | 185 |
Alumis | 109 |
Annexon | 71 |
IGMS News
- 13 days ago - IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 17 days ago - IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay - Market Watch
- 7 weeks ago - IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO - Benzinga
- 7 weeks ago - IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases - Barrons
- 7 weeks ago - IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 7 weeks ago - IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity - GlobeNewsWire
- 2 months ago - IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit - GlobeNewsWire